First Time Loading...

23andMe Holding Co.
NASDAQ:ME

Watchlist Manager
23andMe Holding Co. Logo
23andMe Holding Co.
NASDAQ:ME
Watchlist
Price: 0.5023 USD -0.46% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

ME Price Targets Summary
23andMe Holding Co.

Wall Street analysts forecast ME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ME is 1.2597 USD with a low forecast of 0.4747 USD and a high forecast of 2.1 USD.

ME Lowest Forecast
Wall Street Target
0.4747 USD
5% Downside
ME Average Forecast
Wall Street Target
1.2597 USD
151% Upside
ME Highest Forecast
Wall Street Target
2.1 USD
318% Upside
Lowest
Price Target
0.4747 USD
5% Downside
Average
Price Target
1.2597 USD
151% Upside
Highest
Price Target
2.1 USD
318% Upside
23andMe Holding Co. Competitors:
Price Targets
OPCH
Option Care Health Inc
35% Upside
E
6099
Elan Corp
11% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
1% Upside
O
OPTIMAX
Optimax Holdings Bhd
33% Upside
OPCH
Option Care Health Inc
35% Upside
E
6099
Elan Corp
11% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
1% Upside
O
OPTIMAX
Optimax Holdings Bhd
33% Upside
METROPOLIS
Metropolis Healthcare Ltd
4% Downside
LH
Laboratory Corporation of America Holdings
22% Upside
K
KLINIQ
Klinique Medical Clinic PCL
19% Upside
SHL
Sonic Healthcare Ltd
21% Upside

Revenue
Forecast

Revenue Estimate
23andMe Holding Co.

For the last 3 years the compound annual growth rate for 23andMe Holding Co.'s revenue is -1%. The projected CAGR for the next 3 years is 1%.

-1%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
23andMe Holding Co.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
23andMe Holding Co.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ME intrinsic value, competitors valuation, and company profile.
DCF Valuation
ME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ME stock valuation using valuation multiples.
Wall Street Estimates
ME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ME's stock price target?
Price Target
1.2597 USD

According to Wall Street analysts, the average 1-year price target for ME is 1.2597 USD with a low forecast of 0.4747 USD and a high forecast of 2.1 USD.

What is 23andMe Holding Co.'s Revenue forecast?
Projected CAGR
1%

For the last 3 years the compound annual growth rate for 23andMe Holding Co.'s revenue is -1%. The projected CAGR for the next 3 years is 1%.

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.